Search Results - "Wolf, Julie L."

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Effects of Smoking on the Pharmacokinetics of Erlotinib by HAMILTON, Marta, WOLF, Julie L, RUSK, Jason, BEARD, Shannon E, CLARK, Gary M, WITT, Karsten, CAGNONI, Pablo J

    Published in Clinical cancer research (01-04-2006)
    “…Purpose: To compare the pharmacokinetic variables of erlotinib in current smokers with nonsmokers after receiving a single oral 150 or 300 mg dose of…”
    Get full text
    Journal Article
  2. 2

    The effect of rifampicin, a prototypical CYP3A4 inducer, on erlotinib pharmacokinetics in healthy subjects by Hamilton, Marta, Wolf, Julie L., Drolet, Daniel W., Fettner, Scott H., Rakhit, Ashok K., Witt, Karsten, Lum, Bert L.

    Published in Cancer chemotherapy and pharmacology (01-03-2014)
    “…Purpose Erlotinib, N -(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy) quinazolin-4-amine is approved for the treatment for non-small cell lung cancer and pancreatic…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Trends in intake and outcome data for animal shelters in Colorado, 2000 to 2007 by Morris, Kevin N, Wolf, Julie L, Gies, David L

    “…Objective--To measure trends in animal shelter intake and outcome data for dogs and cats in Colorado on a statewide, urban, and rural basis from 2000 through…”
    Get full text
    Journal Article
  5. 5

    An Evaluation of the Toxicities of 2' -Fluorouridine and 2'-Fluorocytidine-HCI in F344 Rats and Woodchucks (Marmota monax) by Richardson, Frank C., Tennant, Bud C., Meyer, Denny J., Richardson, Katherine A., Mann, Peter C., Mcginty, Gregory R., Wolf, Julie L., Zack, Philip M., Bendele, Raymond A.

    Published in Toxicologic pathology (01-11-1999)
    “…The toxicities of 2'-fluorouridine (2'-FU) and 2'-fluorocytidine-HCl (2'-FC) were separately evaluated in 2 species, male Fischer 344 (F334) rats and…”
    Get full text
    Journal Article
  6. 6
  7. 7